Variant · Snv
IL10RB NM_000628.5(IL10RB):c.646G>A (p.Glu216Lys)
CI-VAR-00108175Explore in graph →p.Glu216LysNM_000628.5:c.646G>AClinVar 568167 rs45469692
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 568167 | Uncertain significance | criteria provided, multiple submitters, no conflicts | 2 | Inflammatory bowel disease 25; Hepatitis B virus, susceptibility to; Uterine corpus endometrial carcinoma; Sarcoma; Melanoma | germline | 6 | Nov 27, 2024 | clinvar |